Bardoxolone-methyl inhibits migration and metabolism in MCF7 cells

Abstract

Bardoxolone-methyl (BAR) is reported to have anti-inflammatory, anti-proliferative and anti-fibrotic effects. BAR activates Nrf2 and may ameliorate oxidative stress through induction of antioxidant genes. However, off-target effects, probably concentration and NFkB-dependent, have limited the clinical use of BAR. Nrf2 regulates expression of antioxidant and mitochondrial genes and has been proposed as a target for both obesity and breast cancer. Therefore, we explored whether BAR can alter migration and proliferation in the MCF7 cell line and whether metabolic function is affected by BAR. Incubation with BAR caused a time-dependent migratory inhibition and an associated decrease in mitochondrial respiration. Both migratory and mitochondrial inhibition by BAR were further enhanced in the presence of fatty acids. In addition to the activation of Nrf2, BAR altered the expression of target mRNA GCLC and UCP1. After 24 h, BAR inhibited both glycolytic capacity, reserve (p < 0.05) and oxidative phosphorylation (p < 0.001) with an associated increase in mitochondrial ROS and loss of intracellular glutathione in MCF7 cells; however, impairment of mitochondrial activity was prevented by N-acetyl cysteine. The fatty acid, palmitate, increased mitochondrial ROS, impaired migration and oxidative phosphorylation but palmitate toxicity towards MCF7 could not be inhibited by N-acetyl cysteine suggesting that they exert effects through different pathways. BAR-activated AKT, induced DNA damage and inhibited cell proliferation. When the proteasome was inhibited, there was loss of BAR-mediated changes in p65 phosphorylation and SOD2 expression suggesting non-canonical NFkB signaling effects. These data suggest that BAR-induced ROS are important in inhibiting MCF7 migration and metabolism by negatively affecting glycolytic capacity and mitochondrial function. ARTICLE HISTORY

Pharmacological effects of the isomeric mixture of alpha and beta amyrin from Protium heptaphyllum: a literature review

“…Currently, researchers are looking for new compounds for the treatment of obesity. Pentacyclic triterpenes have been described in the literature as anti‐inflammatory substances and are promising as a possible therapeutic option, considering obesity is a disease that has in its pathophysiology the inflammation as an aggravating factor for the development of complications .…”

Electrophile Modulation of Inflammation: A Two-Hit Approach

“…CDDO-Me, also known as BAR, RTA402, or CDDO, is a synthetic triterpenoid currently under clinical investigation for treatment of chronic kidney disease and pulmonary hypertension. This electrophile has documented anti-inflammatory, anti-fibrotic and anti-proliferative effects that have led to significant interest in pre-clinical investigations exploring treatment of pathologies with immunological components [148][149][150].…”

Reactive Oxygen and Nitrogen Species–Induced Protein Modifications: Implication in Carcinogenesis and Anticancer Therapy

“…However, RONS-induced controlled pharmacologic Nrf2 upregulation can inhibit cancer cell proliferation and migration. Indeed, bardoxolone-methyl causes mitochondrial ROS-induced Nrf2 activation to downregulate glycolysis and oxidative phosphorylation, to decrease intracellular GSH level and inhibit MCF-7 cell migration (59). In addition, resveratrol, a natural phytoestrogen, significantly upregulates Nrf2 causing SOD3, NQO1, and OGG1 antioxidant gene expression, and inhibited E2-induced breast cancer cell migration and apoptosis induction (60).…”